Malaria in travelers returning from Kenya: failure of self-treatment with pyrimethamine/sulfadoxine.
D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007630:Kenya; D008288:Malaria / Q000188:drug therapy* / Q000517:prevention & control; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*; D014195:Travel
D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; C001678:Maloprim; D013413:Sulfadoxine; D003622:Dapsone; D011739:Pyrimethamine